Trademark Search in Canada

DEMTEGE

View On IC.GC.CA

APPROVED

on 19 Feb 2025

Last Applicant/ Owned by

Teva Pharmaceuticals USA, Inc.

400 Interpace Parkway, Building AParsippany, NJ 07054

Serial Number

2145723 filed on 8^th Nov 2021

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

K1P1J9

DEMTEGE

Trademark usage description

pharmaceutical preparations for the treatment of alimentary, anti-parasitic, autoimmune, blood-related, cancer, cardiovascular, central nervous system Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of alimentary, anti-parasitic, autoimmune, blood-related, cancer, cardiovascular, central nervous system, dermatological, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, musculo-skeletal, neurological, opthalmological, pain, renal, metabolic, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for use in hematology.

Classification kind code

Mark Details

Serial Number

2145723

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 19^th Feb 2025	Advertised
Submitted for opposition 26 on 23^rd Jan 2025	Approved
Submitted for opposition 27 on 23^rd Jan 2025	Approval Notice Sent
Submitted for opposition 22 on 15^th Jan 2025	Search Recorded
Submitted for opposition 287 on 12^th Jul 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 8^th Nov 2021	Filed
Submitted for opposition 1 on 8^th Nov 2021	Created
Submitted for opposition 31 on 8^th Nov 2021	Formalized